Goldstein Stuart L, Krallman Kelli A, Kirby Cassie, Roy Jean-Philippe, Collins Michaela, Fox Kaylee, Schmerge Alexandra, Wilder Sarah, Gerhardt Bradley, Chima Ranjit, Basu Rajit K, Chawla Lakhmir, Fei Lin
Center for Acute Care Nephrology, Cincinnati Children's Hospital, Cincinnati, Ohio, USA.
Department of Pediatrics, Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, USA.
Kidney Int Rep. 2022 May 25;7(8):1842-1849. doi: 10.1016/j.ekir.2022.05.021. eCollection 2022 Aug.
Acute kidney injury (AKI) occurs in one-fourth of children and young adults admitted to pediatric intensive care unit (PICU). Severe AKI (sAKI; Kidney Disease: Improving Global Outcomes stage 2 or 3) is associated with morbidity and mortality. An AKI risk stratification system, the Renal Angina Index (RAI) calculated at 12 hours of admission, exhibits excellent performance to rule out sAKI at 72 hours of admission. We found that integration of urine neutrophil gelatinase-associated lipocalin (NGAL) with RAI improves prediction of sAKI. We now report the first-year results after implementation of our prospective automated RAI-NGAL clinical decision support (CDS) program.
Patients 3 months to 25 years of age were eligible. Admission order sets have a conditional order for urine NGAL released when a 12-hour RAI ≥8. The primary outcome was sAKI any time at days 2 to 4 of admission. We assessed performance of the RAI and RAI+/NGAL to predict the primary outcome.
A total of 1427 unique patients accounted for 1575 admissions. In 147 admissions, RAI was ≥8. RAI <8 had negative predictive value (NPV) of 0.98 (95% CI 0.97-0.99); RAI ≥ 8 had positive predictive value (PPV) of 0.37 (95% CI 0.30-0.46) to predict days 2 to 4 sAKI (area under the receiver operating characteristic curve [AUC-ROC] 0.88 [95% CI 0.84-0.92]). Of 147 RAI+ patients, 89 had NGAL available. RAI/NGAL combination improved PPV (0.64, 95% CI 0.50-0.79) without decrement in NPV (0.98, 95% CI 0.97-0.98).
AKI biomarker assessment directed by risk stratification improves prediction of sAKI in critically ill children and young adults. This CDS process has potential to enrich the population for interventional study, although improvement to adherence to CDS is needed.
急性肾损伤(AKI)发生在四分之一入住儿科重症监护病房(PICU)的儿童和年轻人中。严重急性肾损伤(sAKI;肾脏病:改善全球预后2期或3期)与发病率和死亡率相关。一种AKI风险分层系统,即入院12小时时计算的肾绞痛指数(RAI),在排除入院72小时时的sAKI方面表现出色。我们发现,将尿中性粒细胞明胶酶相关脂质运载蛋白(NGAL)与RAI相结合可改善对sAKI的预测。我们现在报告我们的前瞻性自动化RAI-NGAL临床决策支持(CDS)项目实施后的第一年结果。
年龄在3个月至25岁之间的患者符合条件。入院医嘱集有一个条件医嘱,当12小时RAI≥8时释放尿NGAL。主要结局是入院第2至4天任何时间的sAKI。我们评估了RAI和RAI+/NGAL预测主要结局的性能。
共有1427名不同患者入院1575次。在147次入院中,RAI≥8。RAI<8对预测第2至4天sAKI的阴性预测值(NPV)为0.98(95%CI 0.97-0.99);RAI≥8对预测第2至4天sAKI的阳性预测值(PPV)为0.37(95%CI 0.30-0.46)(受试者操作特征曲线下面积[AUC-ROC]为0.88[95%CI 0.84-0.92])。在147名RAI+患者中,89名有NGAL数据。RAI/NGAL组合提高了PPV(0.64,95%CI 0.50-0.79),而NPV没有降低(0.98,95%CI 0.97-0.98)。
通过风险分层指导的AKI生物标志物评估可改善对危重症儿童和年轻人sAKI的预测。尽管需要改进对CDS的依从性,但这个CDS过程有可能丰富干预研究的人群。